Will cevumeran start a Phase III trial for pancreatic cancer by 2030?
2
70Ṁ122030
57%
chance
1D
1W
1M
ALL
A phase I trial of cevumeran in pancreatic cancer had some pretty [impressive results](https://www.nature.com/articles/s41586-023-06063-y). By 2030 will cevumeran (in combination with other drugs or not) enter a Phase III trial at least partially targeting pancreatic ductal adenocarcinoma?
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000Related questions
Related questions
Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?
50% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
51% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will cancer be cured by 2035?
17% chance
Will we get a cure for cancer before 2030?
13% chance
Will we get a cure for cancer before 2037?
32% chance
Will we get a cure for cancer before 2033?
19% chance
Will we get a cure for cancer before 2031?
15% chance
Will a cure that eradicated over 50% of cancer tumors without significant adverse side effects be found before 2050?
55% chance
Will we get a cure for cancer before 2036?
27% chance